March 26, 2012
Pfizer Poultry Health widens portfolio with acquisition of Alpharma
Press release
Pfizer Poultry Health now offers a wider portfolio of products and services than any other global poultry healthcare provider with the acquisition of Alpharma LLC.
With this acquisition, Pfizer Poultry Health gains a portfolio of medicated feed additives, water-soluble therapeutics and probiotics and enters the poultry nutrition sector.
These products complement Pfizer's existing range of biologicals, pharmaceuticals and devices and establish Pfizer as a full solutions provider to poultry producers, according to said José Francisco Ortiz C., vice president, Pfizer Poultry Health & New Established Brands.
"The integration expands Pfizer Poultry Health's product portfolio and broadens the range of healthcare solutions we can offer our poultry customers. It allows us to enter new therapeutic fields and deliver increased expertise to poultry producers," says Oritz.
The acquisition of Alpharma is part of Pfizer's acquisition of King Pharmaceuticals. Pfizer hopes that the research and development platform it has established, integrated with Alpharma's strong research history, will lead to further advances in poultry health management for poultry producers worldwide.